Delivery Order SPE2DB20D3103-SPE2DB22FN0P0
- Not listed
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $9,966.33 firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc., doing business as Amerisourcebergen, holds with the DLA Troop Support Medical. This comprehensive IDC enables Amerisourcebergen to efficiently supply a wide range of pharmaceutical products and medical supplies,...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,460.19 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 29, 2024. The contract was awarded under the DLA's Troop Support Medical Indefinite Delivery Contract, a large medical commodities vehicle valued up to $999,999,999 through December 2025,...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $31,072.83 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024 with a completion date of July 29, 2024. The contract is a Delivery Order and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,749.29 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of Lotrel 10-40 mg capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,700.85 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 6, 2023. The contract has a completion date of February 7, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,929.42 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Medical Supply Chain, which is an alternate name for the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,896.41, is a delivery order with a firm-fixed price pricing type. It has an ultimate completion date of November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,437.17 firm fixed-price delivery order is for 4563844946 LOTREL 10-20 MG CAPSULE 100S, with a period of performance ending on March 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,896.27 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract, valued at $2,462.96, is a delivery order with a firm fixed price. It has an ultimate completion date of March 11, 2024. The contract is not associated with any set-aside...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN0P0Delivery Order
This federal contract award is for the delivery of LOTREL 10-20 mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The $6,184.11 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order represents one of many orders fulfilled by AmerisourceBergen under the IDC to meet the diverse pharmaceutical needs of the Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 3/18/22 |